Kim G. Jacobs-Van Der Wurff
Utrecht, UT 3584CS, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The Effect of Microbubble-Assisted Ultrasound on Molecular Permeability across Cell Barriers.
Journal: Pharmaceutics
Published: January 24, 2022
Potential Use of Extracellular Vesicles Generated by Microbubble-Assisted Ultrasound as Drug Nanocarriers for Cancer Treatment.
Journal: International journal of molecular sciences
Published: April 01, 2020
Tumor Drug Distribution after Local Drug Delivery by Hyperthermia, In Vivo.
Journal: Cancers
Published: August 09, 2019
MicroRNA-130a Contributes to Type-2 Classical DC-activation in Sjögren's Syndrome by Targeting Mitogen- and Stress-Activated Protein Kinase-1.
Journal: Frontiers in immunology
Published: April 09, 2019
Assessment of Intratumoral Doxorubicin Penetration after Mild Hyperthermia-Mediated Release from Thermosensitive Liposomes.
Journal: Contrast media & molecular imaging
Published: December 05, 2018
Triggered radiosensitizer delivery using thermosensitive liposomes and hyperthermia improves efficacy of radiotherapy: An in vitro proof of concept study.
Journal: PloS one
Published: May 25, 2018
Synovial T cell hyporesponsiveness to myeloid dendritic cells is reversed by preventing PD-1/PD-L1 interactions.
Journal: Arthritis research & therapy
Published: March 14, 2014
Interleukin-7 and Toll-like receptor 7 induce synergistic B cell and T cell activation.
Journal: PloS one
Published: August 23, 2013
Thymic stromal lymphopoietin, a novel proinflammatory mediator in rheumatoid arthritis that potently activates CD1c+ myeloid dendritic cells to attract and stimulate T cells.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: June 13, 2013
Intra-articular CD1c-expressing myeloid dendritic cells from rheumatoid arthritis patients express a unique set of T cell-attracting chemokines and spontaneously induce Th1, Th17 and Th2 cell activity.
Journal: Arthritis research & therapy
Published: December 13, 2012
Clinical efficacy of leflunomide in primary Sjogren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression.
Journal: Annals of the rheumatic diseases
Published: May 08, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026